US Broker Ratings

Prestige Consumer Healthcare (PBH) Stock Analysis: Unveiling a Potential 35% Upside for Investors

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a prominent player in the healthcare sector, specifically within the drug manufacturing industry, focusing on over-the-counter (OTC) health and personal care products...

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Growth, Innovation, and a Strategic Pipeline Fueling Investor Interest

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, has been making waves with its innovative RNA-targeted medicines. With a market capitalization of $11.15 billion and a..

Smith & Nephew (SNN) Stock Analysis: Exploring Growth Amidst a Solid 6.61% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands as a formidable player in the healthcare sector, specifically in the medical devices industry. Headquartered in Watford, United Kingdom, the company boasts..

Legend Biotech Corporation (LEGN) Investor Outlook: Unpacking a 140.9% Potential Upside Amidst a Robust Oncology Pipeline

Legend Biotech Corporation (NASDAQ: LEGN) is capturing investor attention with a remarkable 140.9% potential upside, anchored by its innovative strides in the biotechnology sector. As a leading player in the..

Telix Pharmaceuticals Limited (TLX) Investor Outlook: Unveiling a 117.90% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), a prominent player in the biotechnology industry, has been making waves with its innovative approach to radiopharmaceuticals. With its market capitalization standing at $3.31 billion,..

Doximity, Inc. (DOCS) Stock Analysis: Understanding the 6.86% Potential Upside for Investors

Doximity, Inc. (DOCS), a leader in the health information services sector, has carved out a unique niche in the digital healthcare landscape. With a market capitalization of $12.29 billion, Doximity..

BrightSpring Health Services (BTSG) Stock Analysis: A 5.54% Upside Amid Robust Revenue Growth

BrightSpring Health Services, Inc. (NASDAQ: BTSG) is capturing investor attention with its impressive revenue growth of 29.10% and a potential upside of 5.54% based on the average target price from..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Exploring a 29% Upside in the Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company based in Morrisville, North Carolina, is making waves in the healthcare sector with a promising growth trajectory. The company’s primary focus on..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Volatility with a 65% Potential Upside

Moderna, Inc. (NASDAQ: MRNA) remains a prominent player in the biotechnology sector, primarily recognized for its transformative messenger RNA (mRNA) medicines. With a current market capitalization of $10.44 billion, the..

Revolution Medicines (RVMD) Stock Analysis: Unveiling a 56% Potential Upside Amidst Robust Buy Ratings

Revolution Medicines, Inc. (NASDAQ: RVMD) is capturing investor attention in the biotechnology space with its promising portfolio of targeted therapies for RAS-addicted cancers. As a clinical-stage precision oncology company, Revolution..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unlocking Potential with a 19.51% Upside and Revolutionary Biotech Ventures

BridgeBio Pharma, Inc. (BBIO), a prominent player in the biotechnology sector, has been generating significant interest among investors due to its robust pipeline of transformative medicines and a compelling 19.51%..

STERIS plc (STE) Stock Analysis: Exploring a 15.50% Potential Upside in the Healthcare Sector

Investors eyeing the healthcare sector should take a closer look at STERIS plc (NYSE: STE), a leading provider of infection prevention products and services. With a market capitalization of $23.23..

Exact Sciences Corporation (EXAS) Stock Analysis: Exploring a 14.46% Potential Upside in the Healthcare Sector

Exact Sciences Corporation (NASDAQ: EXAS) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $11.04 billion, the company stands..

Ascendis Pharma A/S (ASND)

⚠️ No article content returned.

..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring an 86% Upside Potential in the Biotech Sector

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company, is garnering significant attention in the biotechnology sector. With its focus on developing novel therapeutics for rare diseases, the company stands..

Halozyme Therapeutics (HALO) Stock Analysis: Robust Revenue Growth and Potential 18.56% Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a significant player in the biotechnology sector, has been capturing attention with its innovative product pipeline and strategic collaborations. Based in San Diego, California, the..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Unveiling a 31% Potential Upside for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the medical instruments and supplies industry, is capturing the attention of investors with its innovative product offerings and a robust..

Edwards Lifesciences Corporation (EW) Stock Analysis: Unlocking an 18% Upside Potential in a Burgeoning Healthcare Sector

Edwards Lifesciences Corporation (NYSE: EW) stands as a prominent player in the healthcare sector, particularly within the medical devices industry. With a current market capitalization of $43.41 billion, the company..

Guardant Health, Inc. (GH) Stock Analysis: A Growth Powerhouse with a 6.81% Upside Potential

Guardant Health, Inc. (NASDAQ: GH), a frontrunner in the precision oncology sector, is making waves in the healthcare industry with its innovative diagnostic solutions. With a current market cap of..

Integer Holdings Corporation (ITGR): Investor Outlook with a Promising 39% Potential Upside

Integer Holdings Corporation (NYSE: ITGR) stands at a pivotal moment for potential investors, boasting a robust market capitalization of $3.54 billion within the healthcare sector. Specializing in the medical devices..

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds